Correlation Between Day One and Passage Bio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Day One and Passage Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Day One and Passage Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Day One Biopharmaceuticals and Passage Bio, you can compare the effects of market volatilities on Day One and Passage Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Day One with a short position of Passage Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Day One and Passage Bio.

Diversification Opportunities for Day One and Passage Bio

0.02
  Correlation Coefficient

Significant diversification

The 3 months correlation between Day and Passage is 0.02. Overlapping area represents the amount of risk that can be diversified away by holding Day One Biopharmaceuticals and Passage Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Passage Bio and Day One is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Day One Biopharmaceuticals are associated (or correlated) with Passage Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Passage Bio has no effect on the direction of Day One i.e., Day One and Passage Bio go up and down completely randomly.

Pair Corralation between Day One and Passage Bio

Given the investment horizon of 90 days Day One Biopharmaceuticals is expected to under-perform the Passage Bio. But the stock apears to be less risky and, when comparing its historical volatility, Day One Biopharmaceuticals is 2.6 times less risky than Passage Bio. The stock trades about -0.11 of its potential returns per unit of risk. The Passage Bio is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest  66.00  in Passage Bio on August 28, 2024 and sell it today you would lose (4.00) from holding Passage Bio or give up 6.06% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Day One Biopharmaceuticals  vs.  Passage Bio

 Performance 
       Timeline  
Day One Biopharmaceu 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Day One Biopharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Day One is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.
Passage Bio 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Passage Bio has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Passage Bio is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Day One and Passage Bio Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Day One and Passage Bio

The main advantage of trading using opposite Day One and Passage Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Day One position performs unexpectedly, Passage Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Passage Bio will offset losses from the drop in Passage Bio's long position.
The idea behind Day One Biopharmaceuticals and Passage Bio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Other Complementary Tools

Share Portfolio
Track or share privately all of your investments from the convenience of any device
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Equity Valuation
Check real value of public entities based on technical and fundamental data